LabCorp
LH
#956
Rank
NZ$45.10 B
Marketcap
NZ$556.22
Share price
-0.65%
Change (1 day)
14.60%
Change (1 year)
Laboratory Corporation of America Holdings or LabCorp is a US company that offers clinical laboratory services. The company supplies laboratory results for the diagnosis of diseases and the development of new drugs.

EPS for LabCorp (LH)

EPS in 2026 (TTM): NZ$21.17

According to LabCorp's latest financial reports the company's current EPS (TTM) is NZ$21.69. In 2025 the company made an earnings per share (EPS) of NZ$18.76 an increase over its 2024 EPS that were of NZ$15.84.

EPS history for LabCorp from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$21.1712.85%
2025NZ$18.7618.45%
2024NZ$15.8489.15%
2023NZ$8.37-66.26%
2022NZ$24.82-43.33%
2021NZ$43.8054.11%
2020NZ$28.4289.43%
2019NZ$15.00-3.33%
2018NZ$15.52-29.7%
2017NZ$22.0875.74%
2016NZ$12.5663.19%
2015NZ$7.70-28.4%
2014NZ$10.75-6.13%
2013NZ$11.455.2%
2012NZ$10.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
IDEXX Laboratories
IDXX
NZ$25.53 17.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$17.00-21.61%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$0.71-103.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$3.54-83.69%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
NZ-$0.37-101.73%๐Ÿ‡บ๐Ÿ‡ธ USA